Cargando…

Successful treatment of type I pityriasis rubra pilaris with ixekizumab

Detalles Bibliográficos
Autores principales: Heibel, Mark D., Heibel, Haley D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141639/
https://www.ncbi.nlm.nih.gov/pubmed/30246123
http://dx.doi.org/10.1016/j.jdcr.2018.05.006
_version_ 1783355740299198464
author Heibel, Mark D.
Heibel, Haley D.
author_facet Heibel, Mark D.
Heibel, Haley D.
author_sort Heibel, Mark D.
collection PubMed
description
format Online
Article
Text
id pubmed-6141639
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61416392018-09-21 Successful treatment of type I pityriasis rubra pilaris with ixekizumab Heibel, Mark D. Heibel, Haley D. JAAD Case Rep Case Report Elsevier 2018-09-14 /pmc/articles/PMC6141639/ /pubmed/30246123 http://dx.doi.org/10.1016/j.jdcr.2018.05.006 Text en © 2018 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Heibel, Mark D.
Heibel, Haley D.
Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title_full Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title_fullStr Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title_full_unstemmed Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title_short Successful treatment of type I pityriasis rubra pilaris with ixekizumab
title_sort successful treatment of type i pityriasis rubra pilaris with ixekizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141639/
https://www.ncbi.nlm.nih.gov/pubmed/30246123
http://dx.doi.org/10.1016/j.jdcr.2018.05.006
work_keys_str_mv AT heibelmarkd successfultreatmentoftypeipityriasisrubrapilariswithixekizumab
AT heibelhaleyd successfultreatmentoftypeipityriasisrubrapilariswithixekizumab